Low-density lipoprotein particle size, central obesity, cardiovascular fitness, and insulin resistance syndrome markers in obese youths.
OBJECTIVE
(1) To determine the prevalence of small dense low-density lipoprotein (SDLDL) particles in obese youths and (2) to compare youths with SDLDL and large buoyant LDL (LBLDL) subclass phenotypes in total body and abdominal fatness, cardiovascular (CV) fitness, and markers of the insulin resistance syndrome (IRS).


METHODS
For group comparisons, subjects were dichotomized into either SDLDL phenotype group or LBDL phenotype group based on LDL particle size.


METHODS
Obese 13 to 16-y-olds (n=80) who had a triceps skinfold greater than the 85th percentile for gender, ethnicity, and age.


METHODS
LDL particle size, plasma lipids and lipoprotein concentrations, plasma glucose and insulin concentrations, and blood pressures; percentage body fat, visceral adipose tissue (VAT); VO(2) at a heart rate of 170 bpm as an index of CV fitness.


RESULTS
The prevalence of the SDLDL phenotype was 54% among the 80 obese youths. Although overall body fatness (ie BMI and percentage body fat) and CV fitness were similar between the two LDL phenotype groups, the SDLDL phenotype group had significantly higher weight, waist circumference and VAT than the LBLDL phenotype group. With respect to the IRS markers, youths with the SDLDL phenotype had significantly higher triacylglycerol (TAG), very low-density lipoprotein cholesterol (VLDLC), apolipoprotein B (apo B), and total cholesterol-to-high-density lipoprotein ratio (TC/HDLC) than youths with the LBLDL phenotype. LDL particle size as a continuous variable was significantly correlated with TAG, VLDLC, apo B, HDLC, and TC/HDLC. Plasma TAG and HDLC concentrations were independent predictors of LDL particle size.


CONCLUSIONS
(1) The SDLDL phenotype was common in obese youths and (2) the relationships of LDL particle size with several of the IRS markers suggested that already in adolescence the expression of the SDLDL phenotype might be an important risk factor for future coronary heart disease mortality and morbidity.
Kang
H-S
HS
Georgia Prevention Institute, Department of Pediatrics, Medical College of Georgia, Augusta, Georgia 30912-3710, USA. hkang@mail.mcg.edu
Gutin
B
B
Barbeau
P
P
Litaker
M S
MS
Allison
J
J
Le
N-A
NA
D000005:Abdomen; D000273:Adipose Tissue; D000293:Adolescent; D001053:Apolipoproteins / Q000097:blood; D044383:Black People / Q000235:genetics; D001794:Blood Pressure; D001823:Body Composition; D002784:Cholesterol / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood / Q000737:chemistry*; D005260:Female; D005845:Georgia / Q000453:epidemiology; D006439:Hemodynamics / Q000502:physiology; D006801:Humans; D007333:Insulin Resistance / Q000235:genetics*; D008074:Lipoproteins / Q000097:blood*; D008297:Male; D009765:Obesity / Q000097:blood / Q000453:epidemiology* / Q000235:genetics; D010316:Particle Size; D010641:Phenotype; D010809:Physical Fitness; D015995:Prevalence; D012885:Skinfold Thickness; D044465:White People / Q000235:genetics; D001741:Black or African American
D001053:Apolipoproteins; D008078:Cholesterol, LDL; D008074:Lipoproteins; D002784:Cholesterol